MUTO FREDERICK T 4

4 · IONIS PHARMACEUTICALS INC · Filed Jun 17, 2021

Form 4

Period: 2021-06-15

Director

Transactions

Exercise/Conversion
Common Stock
2021-06-15$9.30/sh+5,000$46,500→ 36,683 total
Sale
Common Stock
2021-06-15$36.55/sh−5,000$182,750→ 31,683 total
Sale
Common Stock
2021-06-15$36.85/sh−5,000$184,250→ 31,683 total
Sale
Common Stock
2021-06-15$36.50/sh−5,000$182,500→ 31,683 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-06-15−5,000→ 10,000 total
Exercise: $9.30From: 2012-07-01Exp: 2021-06-30→ Common Stock (5,000 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-06-15−5,000→ 5,000 total
Exercise: $9.30From: 2012-07-01Exp: 2021-06-30→ Common Stock (5,000 underlying)
Exercise/Conversion
Common Stock
2021-06-15$9.30/sh+5,000$46,500→ 36,683 total
Exercise/Conversion
Common Stock
2021-06-15$9.30/sh+5,000$46,500→ 36,683 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-06-15−5,000→ 0 total
Exercise: $9.30From: 2012-07-01Exp: 2021-06-30→ Common Stock (5,000 underlying)

Footnotes (2)

[F1]Acquired as a result of exercising a stock option that was scheduled to expire on June 30, 2021. The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020.
[F2]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020.

Documents

1 file